Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer

Biomedical Papers

Volumn 154, Issue 4, 2010, Pages 321-326

  Janikova, Maria ^a   Skarda, Jozef ^a   Dziechciarkova, Marta ^a   Radova, Lenka ^a   Chmelova, Jana ^a   Krejci, Veronika ^a   Sedlakova, Eva ^a   Zapletalova, Jana ^a   Langova, Katerina ^a   Klein, Jiri ^a   Grygarkova, Ivona ^a   Kolek, Vitezslav ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Cancer stem cell (CSC); CD133; Immunofluorescence; Nestin; Non small cell lung cancer (NSCLC)

Indexed keywords

EID: 78650815862     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2010.048     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Okamoto OK. Cancer stem cell genomics: the quest for early markers of malignant progression. Expert Rev Mol Diagn 2009;9:545-554.
3. Chiba T, Kamiya A, Yokosuka O, Iwama A. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective. Cancer Lett 2009;286:145-153.
4. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.
5. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828.
6. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20:102-107.
7. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 2004;57:965-969.
8. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007;6:92-97.
9. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542-2556.
10. Bruno S, Bussolati B, Grange C, Collino F, Graziano ME, Ferrando U et al. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 2006;169:2223-2235.
11. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110.
12. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-10951.
13. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008;214:3-9.
14. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760.
15. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133 - metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-2120.
16. Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerová H et al. The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 2008;56:977-993.
17. Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 2008;27:85.
18. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504-514.
19. Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 2006;111:272-277.
20. Yang XH, Wu QL, Yu XB, Xu CX, Ma BF, Zhang XM et al. Nestin expression in different tumours and its relevance to malignant grade. J Clin Pathol 2008;61:467-473.
21. Sugawara K, Kurihara H, Negishi M, Saito N, Nakazato Y, Sasaki T et al. Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 2002;82:345-351.
22. Lobo MV, Arenas MI, Alonso FJ, Gomez G, Bazán E, Paíno CL et al. Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res 2004;316:369-376.
23. Ehrmann J, Kolar Z, Mokry J. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J Clin Pathol 2005;58:222-223.
24. Lachenmayer A, Lichtenauer UD, Cox T, Schott M, Malendowicz LK, Goretzki PE et al. Nestin as a marker in the classification of adrenocortical tumors. Horm Metab Res 2009;41:397-401.
25. Brychtova S, Fiuraskova M, Brychta T, Hirnak J. The role of intermedial filament nestin in malignant melanoma progression. Cesk Patol 2005;41:143-145.
26. Messam CA, Hou J, Berman JW, Major EO. Analysis of the temporal expression of nestin in human fetal brain derived neuronal and glial progenitor cells. Brain Res Dev Brain Res 2002;134:87-92.
27. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, editors. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press;2004.
28. Casella GT, Bunge MB, Wood PM. Improved immunocytochemical identification of neural, endothelial, and inflammatory cell types in paraffin-embedded injured adult rat spinal cord. J Neurosci Methods 2004;139:1-11.
29. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 2009;106:16281-16286.
30. Yamamoto A, Shofuda T, Islam MO, Nakamura Y, Yamasaki M, Okano H et al. ABCB1 is predominantly expressed in human fetal neural stem/progenitor cells at an early development stage. J Neurosci Res 2009;87:2615-2623.
31. Salnikov AV, Gladkich J, Moldenhauer G, Volm M, Mattern J, Herr I. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients. Int J Cancer 2010;126:950-958.
32. Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Vesely K et al. Nestin expression in osteosarcomas and derivation of nestin/ CD133 positive osteosarcoma cell lines. BMC Cancer 2008;8:300.
33. Mokry J, Cizkova D, Filip S, Ehrmann J, Osterreicher J, Kolar Z et al. Nestin expression by newly formed human blood vessels. Stem Cells Dev 2004;13:658-664.
34. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11:69-82.